2020 American Transplant Congress
Impact of Extended- versus Immediate-Release Tacrolimus on One-Year Development of De Novo DSA and Chronic Immune Activation in Kidney Transplantation (ASTOUND Study)
*Purpose: To compare, using an adaptive study design, the 1-year incidence of a novel two-part composite endpoint consisting of de novo donor-specific antibody (dnDSA) formation…2020 American Transplant Congress
Glomerular Filtration Rate Based on Cystatin C Provides the Best Prediction of Cardiovascular Events and Mortality Compared to Measured GFR and Creatinine Based GFR in Kidney Transplant Recipients
1Mayo Clinic, Scottsdale, AZ, 2Mayo Clinic, Rochester, MN
*Purpose: GFR estimated by cystatin C (CysC) is a better predictor of cardiovascular (CV) events and mortality compared to eGFR by creatinine (Cr) in native…2020 American Transplant Congress
Waitlist-Conditioned Transplant Rate is Not an Appropriate Metric for Benchmarking Access to Kidney Transplantation
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Transplant rate is used as a primary metric of center performance as reported by the SRTR. However, the calculation of transplant rate can be…2020 American Transplant Congress
Pathogenesis of Polyomavirus BK Nephropathy (BKVN): Insights from Quantitative Proteomics Profiling
*Purpose: Our current understanding of the pathogenesis of BKVN is based primarily on transcriptomics studies. However, proteins are the final effector molecules that mediate tissue…2020 American Transplant Congress
Evaluation of an Opioid Restrictive Pain Management Initiative in Adult Kidney Transplant Recipients
1Michigan Medicine - University of Michigan, Ann Arbor, MI, 2ProHealth Care, Milwaukee, WI
*Purpose: Recent national policy changes make it imperative to implement practices to reduce opioid prescribing. Despite the importance, evidence to guide opioid utilization following kidney…2020 American Transplant Congress
Effect of Glecaprevir/Pibrentasvir on Weight-Adjusted Tacrolimus Trough/Dose Ratios in Heart and Kidney Recipients
*Purpose: An innovative strategy to meet the demands of patients requiring heart or kidney transplantation is the acceptance of hepatitis C viremic organs. Direct acting…2020 American Transplant Congress
Epitope Analysis of Complement-Binding De Novo Donor-Specific HLA Class II Antibody
*Purpose: Patients with de novo donor specific antibody (dnDSA) after kidney transplantation have a poorer prognosis than patients without dnDSA. Meanwhile, patients with dnDSA do…2020 American Transplant Congress
Health Professional Level Barriers to Living Donor Kidney Transplantation: A Mixed Methods Study
1McGill University, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada
*Purpose: Despite the benefits of living donor kidney transplantation (LDKT), rates have stagnated. Efforts to increase LDKT have focused on patient level barriers. Health professionals…2020 American Transplant Congress
Incidence and Risk Factors of Post-Transplant Erythrocytosis in Deceased Donor Kidney Transplantation
*Purpose: Post-transplant erythroytosis (PTE) is clinically important condition after kidney transplantation (KTx). Previously published literature from single-center studies, demonstrated variable incidence rates between 8-15%. We…2020 American Transplant Congress
Can a Patient with Von Willebrand Disease Donate a Kidney?
*Purpose: Von Willebrand disease (VWD) is a haematological condition that can be challenging to deal with during any operative intervention. We report a successful example…
- « Previous Page
- 1
- …
- 161
- 162
- 163
- 164
- 165
- …
- 531
- Next Page »